Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients
HCV damages the hepatocytes ending with hepatocellular carcinoma (HCC). The direct-acting antivirals (DAAs) treatment has raised hopes for reducing the incidence of HCC. However, several scientific debate regarding the impact of DAAs on the occurrence of HCC in patients with cirrhosis. We aimed to s...
Main Authors: | Reham M. Dawood, Mai Abd El-Meguid, Hend Ibrahim Shousha, Ahmed Elsayed, Mohamed Mahmoud Nabeel, Ayman Yosry, Ashraf Abdelaziz, Ghada M. Salum |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022014074 |
Similar Items
-
Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01) -
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals
by: Dimitrios N. Samonakis, et al.
Published: (2021-03-01) -
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)
by: Vincenzo Scaglione, et al.
Published: (2020-02-01) -
Impact of interferon-free regimens in patients with chronic HCV and successfully ablated HCC
by: Amr Maged Mahmoud Rasheed, et al.
Published: (2025-02-01) -
Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
by: Zuzana Macek Jilkova, et al.
Published: (2021-12-01)